These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 32630552)

  • 1. Tumor-Suppressive miR-192-5p Has Prognostic Value in Pancreatic Ductal Adenocarcinoma.
    Flammang I; Reese M; Yang Z; Eble JA; Dhayat SA
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32630552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Impact of Epithelial-to-Mesenchymal Transition Regulating MicroRNAs in Pancreatic Ductal Adenocarcinoma.
    Dhayat SA; Traeger MM; Rehkaemper J; Stroese AJ; Steinestel K; Wardelmann E; Kabar I; Senninger N
    Cancers (Basel); 2018 Sep; 10(9):. PubMed ID: 30217058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of Exosomal microRNA-200b as Liquid Biopsy Marker in Pancreatic Ductal Adenocarcinoma.
    Reese M; Flammang I; Yang Z; Dhayat SA
    Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31941049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ambiguous role of microRNA-205 and its clinical potential in pancreatic ductal adenocarcinoma.
    Michael Traeger M; Rehkaemper J; Ullerich H; Steinestel K; Wardelmann E; Senninger N; Abdallah Dhayat S
    J Cancer Res Clin Oncol; 2018 Dec; 144(12):2419-2431. PubMed ID: 30244390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-296-5p Promotes Cell Invasion and Drug Resistance by Targeting Bcl2-Related Ovarian Killer, Leading to a Poor Prognosis in Pancreatic Cancer.
    Okazaki J; Tanahashi T; Sato Y; Miyoshi J; Nakagawa T; Kimura T; Miyamoto H; Fujino Y; Nakamura F; Takehara M; Ma B; Bando M; Kitamura S; Okamoto K; Muguruma N; Sogabe M; Takayama T
    Digestion; 2020; 101(6):794-806. PubMed ID: 31563901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-3940-5p/miR-8069 ratio in urine exosomes is a novel diagnostic biomarker for pancreatic ductal adenocarcinoma.
    Yoshizawa N; Sugimoto K; Tameda M; Inagaki Y; Ikejiri M; Inoue H; Usui M; Ito M; Takei Y
    Oncol Lett; 2020 Apr; 19(4):2677-2684. PubMed ID: 32218818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Exosomal miRNA-1226 as Potential Biomarker of Pancreatic Ductal Adenocarcinoma.
    Wang C; Wang J; Cui W; Liu Y; Zhou H; Wang Y; Chen X; Chen X; Wang Z
    Onco Targets Ther; 2021; 14():1441-1451. PubMed ID: 33664577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical impact of circulating LAPTM4B-35 in pancreatic ductal adenocarcinoma.
    Yang Z; Senninger N; Flammang I; Ye Q; Dhayat SA
    J Cancer Res Clin Oncol; 2019 May; 145(5):1165-1178. PubMed ID: 30778748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4.
    Fu Y; Liu X; Chen Q; Liu T; Lu C; Yu J; Miao Y; Wei J
    J Exp Clin Cancer Res; 2018 Jul; 37(1):130. PubMed ID: 29970191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-122-5p inhibits cell proliferation, migration and invasion by targeting CCNG1 in pancreatic ductal adenocarcinoma.
    Dai C; Zhang Y; Xu Z; Jin M
    Cancer Cell Int; 2020; 20():98. PubMed ID: 32256207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating microRNA-99 family as liquid biopsy marker in pancreatic adenocarcinoma.
    Stroese AJ; Ullerich H; Koehler G; Raetzel V; Senninger N; Dhayat SA
    J Cancer Res Clin Oncol; 2018 Dec; 144(12):2377-2390. PubMed ID: 30225540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
    Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
    Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 14. MiR-345-5p functions as a tumor suppressor in pancreatic cancer by directly targeting CCL8.
    Mou T; Xie F; Zhong P; Hua H; Lai L; Yang Q; Wang J
    Biomed Pharmacother; 2019 Mar; 111():891-900. PubMed ID: 30841468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulated MicroRNA-483-3p is an Early Event in Pancreatic Ductal Adenocarcinoma (PDAC) and as a Powerful Liquid Biopsy Biomarker in PDAC.
    Shao H; Zhang Y; Yan J; Ban X; Fan X; Chang X; Lu Z; Wu Y; Zong L; Mo S; Yu S; Chen J
    Onco Targets Ther; 2021; 14():2163-2175. PubMed ID: 33790579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomal miR-125b-5p derived from cancer-associated fibroblasts promotes the growth, migration, and invasion of pancreatic cancer cells by decreasing adenomatous polyposis coli (APC) expression.
    Guo Y; Li H; Sun C
    J Gastrointest Oncol; 2023 Apr; 14(2):1064-1076. PubMed ID: 37201069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-138-5p suppresses lung adenocarcinoma cell epithelial-mesenchymal transition, proliferation and metastasis by targeting ZEB2.
    Zhu D; Gu L; Li Z; Jin W; Lu Q; Ren T
    Pathol Res Pract; 2019 May; 215(5):861-872. PubMed ID: 30712885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum miR-210-3p can be used to differentiate between patients with pancreatic ductal adenocarcinoma and chronic pancreatitis.
    Guz M; Jeleniewicz W; Cybulski M; Kozicka J; Kurzepa J; Mądro A
    Biomed Rep; 2021 Jan; 14(1):10. PubMed ID: 33235725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-operative Plasma miR-21-5p Is a Sensitive Biomarker and Independent Prognostic Factor in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgical Resection.
    Karasek P; Gablo N; Hlavsa J; Kiss I; Vychytilova-Faltejskova P; Hermanova M; Kala Z; Slaby O; Prochazka V
    Cancer Genomics Proteomics; 2018; 15(4):321-327. PubMed ID: 29976637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of miR-124 predicts poor prognosis in pancreatic ductal adenocarcinoma patients.
    Sun B; Liu X; Gao Y; Li L; Dong Z
    Br J Biomed Sci; 2016 Oct; 73(4):152-157. PubMed ID: 27922430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.